Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimekizumab in active nonradiographic axial spondyloarthritis
NCT03928704Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2019
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of bimekizumab in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by UCB. Started Apr 2019; status: completed.
02
Drugs
bimekizumab
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT03928704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928704.